Prime-boost strategies combining DNA and inactivated vaccines confer high immunity and protection in cattle against bovine herpesvirus-1

Vaccine

Volumn 23, Issue 43, 2005, Pages 5073-5081

  Toussaint, J F ^a   Letellier, C ^a   Paquet, D ^a   Dispas, M ^a   Kerkhofs, P ^a  

^a VETERINARY AND AGROCHEMICAL RESEARCH CENTRE   (Belgium)

Author keywords

BoHV 1; DNA; Marker vaccine; Prime boost

Indexed keywords

BAYOVAC IBR MARKER INACTIVUM; DNA VACCINE; GAMMA INTERFERON; GLYCOPROTEIN D; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2; INACTIVATED VACCINE; MARKER VACCINE; PRIMER DNA; PROTEIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BOVINE HERPES VIRUS; CATTLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATION ANALYSIS; GENETIC CODE; HERPES VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; INTERFERON PRODUCTION; NONHUMAN; PRIORITY JOURNAL; TH2 CELL; VACCINATION; VIRUS SHEDDING;

ANIMALS; ANTIBODIES, VIRAL; CATTLE; GLYCOPROTEINS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, BOVINE; HERPESVIRUS VACCINES; IMMUNIZATION, SECONDARY; TIME FACTORS; VACCINES, DNA; VACCINES, INACTIVATED;

EID: 24944539630     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.06.006     Document Type: Article

References (68)

1. L.A. Babiuk, R. Pontarollo, S. Babiuk, B. Loehr, and S. Van Drunen Little-van den Hurk Induction of immune responses by DNA vaccines in large animals Vaccine 21 7-8 2003 649 658
2. A.J. Ramsay, K.H. Leong, and I.A. Ramshaw DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors Immunol Cell Biol 75 4 1997 382 388
3. S.J. Kent, A. Zhao, S.J. Best, J.D. Chandler, D.B. Boyle, and I.A. Ramshaw Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus J Virol 72 12 1998 10180 10188
4. R.R. Amara, F. Villinger, J.D. Altman, S.L. Lydy, S.P. O'Neil, and S.I. Staprans Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine Science 292 5514 2001 69 74
5. J. Schneider, J.A. Langermans, S.C. Gilbert, T.J. Blanchard, S. Twigg, and S. Naitza A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees Vaccine 19 32 2001 4595 4602
6. W.O. Rogers, J.K. Baird, A. Kumar, J.A. Tine, W. Weiss, and J.C. Aguiar Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques Infect Immun 69 9 2001 5565 5572
7. P. Pancholi, D.H. Lee, Q. Liu, C. Tackney, P. Taylor, and M. Perkus DNA prime/canarypox boost-based immunotherapy of chronic hepatitis B virus infection in a chimpanzee Hepatology 33 2 2001 448 454
8. Z. Hel, J. Nacsa, E. Tryniszewska, W.P. Tsai, R.W. Parks, and D.C. Montefiori Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses J Immunol 169 9 2002 4778 4787
9. N.A. Doria-Rose, C.C. Pierce, M.T. Hensel, W.F. Sutton, N. Sheikh, and P. Polacino Multigene DNA prime-boost vaccines for SHIV89.6P J Med Primatol 32 4-5 2003 218 228
10. N.J. Sullivan, A. Sanchez, P.E. Rollin, Z.Y. Yang, and G.J. Nabel Development of a preventive vaccine for Ebola virus infection in primates Nature 408 6812 2000 605 609
11. J.W. Shiver, T.M. Fu, L. Chen, D.R. Casimiro, M.E. Davies, and R.K. Evans Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity Nature 415 6869 2002 331 335
12. D.R. Casimiro, A. Tang, L. Chen, T.M. Fu, R.K. Evans, and M.E. Davies Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene J Virol 77 13 2003 7663 7668
13. L. Vinner, E.G. Wee, S. Patel, S. Corbet, G.P. Gao, and C. Nielsen Immunogenicity in Mamu-A*01 rhesus macaques of a CCR5-tropic human immunodeficiency virus type 1 envelope from the primary isolate (Bx08) after synthetic DNA prime and recombinant adenovirus 5 boost J Gen Virol 84 Pt 1 2003 203 213
14. H.M. Vordermeier, D.B. Lowrie, and R.G. Hewinson Improved immunogenicity of DNA vaccination with mycobacterial HSP65 against bovine tuberculosis by protein boosting Vet. Microbiol. 93 4 2003 349 359
15. M.A. Skinner, B.M. Buddle, D.N. Wedlock, D. Keen, L.G. de, and R.E. Tascon A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis Infect Immun 71 9 2003 4901 4907
16. W.P. Cheevers, K.R. Snekvik, J.D. Trujillo, N.M. Kumpula-McWhirter, K.J. Pretty On Top, and D.P. Knowles Prime-boost vaccination with plasmid DNA encoding caprine-arthritis encephalitis lentivirus env and viral SU suppresses challenge virus and development of arthritis Virology 306 1 2003 116 125
17. A.M. Lopez, M.T. Hines, G.H. Palmer, D.P. Knowles, D.C. Alperin, and S.A. Hines Analysis of anamnestic immune responses in adult horses and priming in neonates induced by a DNA vaccine expressing the vapA gene of Rhodococcus equi Vaccine 21 25-26 2003 3815 3825
18. S.K. Tikoo, M. Campos, and L.A. Babiuk Bovine herpesvirus 1 (BHV-1): biology, pathogenesis, and control Adv. Virus Res. 1995 45191 45223
19. J.T. van Oirschot, M.J. Kaashoek, and F.A. Rijsewijk Advances in the development and evaluation of bovine herpesvirus 1 vaccines Vet. Microbiol. 53 1-2 1996 43 54
20. Rijsewijk FA, Kaashoek MJ, Madic J, Paal H, Ruuls R, Gielkens AL, et al. Characterisation of DNA rearrangement found in the unique short region of the Za strain of bovine herpesvirus type 1 and the vaccine properties of this strain. In: Proceeding of the 18th International Herpesvirus Workshop, vol. 67, Pittsburgh; 1993.
21. M.J. Kaashoek, A. Moerman, J. Madic, F.A. Rijsewijk, J. Quak, and A.L. Gielkens A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine Vaccine 12 5 1994 439 444
22. M.J. Kaashoek, A. Moerman, J. Madic, K. Weerdmeester, M. Maris-Veldhuis, and F.A. Rijsewijk An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation Vaccine 13 4 1995 342 346
23. W. Strube, S. Auer, W. Block, E. Heinen, D. Kretzdorn, and C. Rodenbach A gE deleted infectious bovine rhinotracheitis marker vaccine for use in improved bovine herpesvirus 1 control programs Vet Microbiol 53 1-2 1996 181 189
24. M.J. Kaashoek, and J.T. van Oirschot Early immunity induced by a live gE-negative bovine herpesvirus 1 marker vaccine Vet Microbiol 53 1-2 1996 191 197
25. J.C. Bosch, M.J. Kaashoek, A.H. Kroese, and J.T. van Oirschot An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccines Vet Microbiol 52 3-4 1996 223 234
26. J.C. Bosch, M.J. Kaashoek, and J.T. van Oirschot Inactivated bovine herpesvirus 1 marker vaccines are more efficacious in reducing virus excretion after reactivation than a live marker vaccine Vaccine 15 1997 1512 1517
27. J.C. Bosch, J.M. de, P. Franken, K. Frankena, J.J. Hage, and M.J. Kaashoek An inactivated gE-negative marker vaccine and an experimental gD-subunit vaccine reduce the incidence of bovine herpesvirus 1 infections in the field Vaccine 16 2-3 1998 265 271
28. M.H. Mars, M. de Jong, P. Franken, and J.T. van Oirschot Efficacy of a live glycoprotein E-negative bovine herpesvirus 1 vaccine in cattle in the field Vaccine 19 15-16 2001 1924 1930
29. M. Dispas, M. Lemaire, N. Speybroeck, D. Berkvens, A. Dupont, and F. Boelart Deux protocoles d'hyperimmunisation au moyen de vaccins marqués réduisent l'incidence de séroconversion envers l'herpèsvirus bovin 1 en cheptels laitiers: résultats d'une étude sur le terrain Ann Med Vet 148 1 2004 47 61
30. P. Kerkhofs, X. Renjifo, J.F. Toussaint, C. Letellier, E. Vanopdenbosch, and G. Wellemans Enhancement of the immune response and virological protection of calves against bovine herpesvirus type 1 with an inactivated gE-deleted vaccine Vet Rec 152 22 2003 681 686
31. G.J. Cox, T.J. Zamb, and L.A. Babiuk Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA J Virol 67 9 1993 5664 5667
32. Toussaint J.F, Coen L, Letellier C, Dispas M, Gillet L, Vanderplasschen A, et al. Genetic immunization of cattle against Bovine herpesvirus 1: glycoprotein gD confers higher protection than glycoprotein gC or tegument protein VP8. Vet Res 2005;36(4):529-44.
33. P.J. Lewis, G.J. Cox, S. Van Drunen Little-van den Hurk, and L.A. Babiuk Polynucleotide vaccines in animals: enhancing and modulating responses Vaccine 15 8 1997 861 864
34. S. Van Drunen Little-van den Hurk, R.P. Braun, P.J. Lewis, B.C. Karvonen, M.E. Baca-Estrada, and M. Snider Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle J Gen Virol 79 Pt 4 1998 831 839
35. P.J. Lewis, S. Van Drunen Little-van den Hurk, and L.A. Babiuk Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response J Virol 73 12 1999 10214 10223
36. R.P. Braun, L.A. Babiuk, B.I. Loehr, and S. Van Drunen Little-van den Hurk Particle-mediated DNA immunization of cattle confers long-lasting immunity against bovine herpesvirus-1 Virology 265 1 1999 46 56
37. B.I. Loehr, P. Willson, L.A. Babiuk, and S. Van Drunen Little-van den Hurk Gene gun-mediated DNA immunization primes development of mucosal immunity against bovine herpesvirus 1 in cattle J Virol 74 13 2000 6077 6086
38. B.I. Loehr, R. Rankin, R. Pontarollo, T. King, P. Willson, and L.A. Babiuk Suppository-mediated DNA immunization induces mucosal immunity against bovine herpesvirus-1 in cattle Virology 289 2 2001 327 333
39. P.K. Gupta, M. Saini, L.K. Gupta, V.D. Rao, S.K. Bandyopadhyay, and G. Butchaiah Induction of immune responses in cattle with a DNA vaccine encoding glycoprotein C of bovine herpesvirus-1 Vet Microbiol 78 4 2001 293 305
40. S. Babiuk, M.E. Baca-Estrada, M. Foldvari, M. Storms, D. Rabussay, and G. Widera Electroporation improves the efficacy of DNA vaccines in large animals Vaccine 20 27-28 2002 3399 3408
41. S. Suradhat, R.P. Braun, P.J. Lewis, L.A. Babiuk, S. Van Drunen Little-van den Hurk, and P.J. Griebel Fusion of C3d molecule with bovine rotavirus VP7 or bovine herpesvirus type 1 glycoprotein D inhibits immune responses following DNA immunization Vet Immunol Immunopathol 83 1-2 2001 79 92
42. R.A. Pontarollo, L.A. Babiuk, R. Hecker, and S. Van Drunen Little-van den Hurk Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors J Gen Virol 83 Pt 12 2002 2973 2981
43. S. Manoj, P.J. Griebel, L.A. Babiuk, and S. Van Drunen Little-van den Hurk Targeting with bovine CD154 enhances humoral immune responses induced by a DNA vaccine in sheep J Immunol 170 2 2003 989 996
44. S. Manoj, P.J. Griebel, L.A. Babiuk, and S. Van Drunen Little-van den Hurk Modulation of immune responses to bovine herpesvirus-1 in cattle by immunization with a DNA vaccine encoding glycoprotein D as a fusion protein with bovine CD154 Immunology 112 2 2004 328 338
45. G. Castrucci, F. Frigeri, D. Salvatori, M. Ferrari, M.L. Dico, and A. Rotola A study on latency in calves by five vaccines against bovine herpesvirus-1 infection Comp Immunol Microbiol Infect Dis 25 4 2002 205 215
46. Toussaint JF, Rziha HJ, Bauer B, Letellier C, Kerkhofs P. Effects of hypervaccination with bovine herpesvirus 1 gE-deleted marker vaccines on serological response and virological status after challenge with wild-type virus. Vet Rec 2004;155(18):553-58.
47. J. Godfroid, G. Czaplicki, P. Kerkhofs, V. Weynants, G. Wellemans, and E. Thiry Assessment of the cell-mediated immunity in cattle infection after bovine herpesvirus 4 infection, using an in vitro antigen-specific interferon-gamma assay Vet Microbiol 53 1-2 1996 133 141
48. L.A. Babiuk, S. Van Drunen Little-van den Hurk, and S.L. Babiuk Immunization of animals: from DNA to the dinner plate Vet Immunol Immunopathol 72 1-2 1999 189 202
49. H. McShane Prime-boost immunization strategies for infectious diseases Curr Opin Mol Ther 4 1 2002 23 27
50. B.I. Loehr, R. Pontarollo, R. Rankin, L. Latimer, P. Willson, and L.A. Babiuk Priming by DNA immunization augments T-cell responses induced by modified live bovine herpesvirus vaccine J Gen Virol 82 Pt 12 2001 3035 3043
51. M. Lemaire, F. Schynts, G. Meyer, J.P. Georgin, E. Baranowski, and A. Gabriel Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies Vaccine 19 32 2001 4795 4804
52. M. Dispas, F. Schynts, M. Lemaire, C. Letellier, E. Vanopdenbosch, and E. Thiry Isolation of a glycoprotein E-deleted bovine herpesvirus type 1 strain in the field Vet Rec 153 7 2003 209 212
53. F. Schynts, A. Vanderplasschen, E. Hanon, F.A. Rijsewijk, J.T. van Oirschot, and E. Thiry Use of PCR and immunofluorescence to detect bovine herpesvirus 1 recombinants J Virol Methods 92 1 2001 99 104
54. F. Schynts, F. Meurens, B. Detry, A. Vanderplasschen, and E. Thiry Rise and survival of bovine herpesvirus 1 recombinants after primary infection and reactivation from latency J Virol 77 23 2003 12535 12542
55. E. Thiry, F. Meurens, B. Muylkens, M. McVoy, S. Gogev, and J. Thiry Recombination in alphaherpesviruses Rev Med Virol 15 2 2005 89 103
56. F. Meurens, F. Schynts, G.M. Keil, B. Muylkens, A. Vanderplasschen, and P. Gallego Superinfection prevents recombination of the alphaherpesvirus bovine herpesvirus 1 J Virol 78 8 2004 3872 3879
57. H.W. Barkema, C.J. Bartels, L. van Wuijckhuise, J.W. Hesselink, M. Holzhauer, and M.F. Weber Outbreak of bovine virus diarrhea on Dutch dairy farms induced by a bovine herpesvirus 1 marker vaccine contaminated with bovine virus diarrhea virus type 2 Tijdschr Diergeneeskd 126 6 2001 158 165
58. E. Thiry, P. Detilleux, A. De Vriese, M. Pirak, and P.P. Pastoret La rhinotrachéite infectieuse bovine en période néonatale: revue et exposé d'un cas Ann Méd Vét 128 1984 33 40
59. A.M. Menanteau-Horta, T.R. Ames, D.W. Johnson, and J.C. Meiske Effect of maternal antibody upon vaccination with infectious bovine rhinotracheitis and bovine virus diarrhea vaccines Can J Comp Med 49 1985 10 14
60. S. Van Drunen Little-van den Hurk, R.P. Braun, P.J. Lewis, B.C. Karvonen, L.A. Babiuk, and P.J. Griebel Immunization of neonates with DNA encoding a bovine herpesvirus glycoprotein is effective in the presence of maternal antibodies Viral Immunol 12 1 1999 67 77
61. A. Bot, and C. Bona Genetic immunization of neonates Microbes Infect 4 4 2002 511 520
62. S. van Drunen Littel-van den Hurk, S.L. Babiuk, and L.A. Babiuk Strategies for improved formulation and delivery of DNA vaccines to veterinary target species Immunol Rev 2004 199113 199125
63. N.A. Doria-Rose, and N.L. Haigwood DNA vaccine strategies: candidates for immune modulation and immunization regimens Methods 31 3 2003 207 216
64. S. Van Drunen Little-van den Hurk, D.J. Van, J. Kowalski, J.V. van den Hurk, R. Harland, and L.A. Babiuk A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle Vaccine 12 14 1994 1295 1302
65. L.A. Babiuk, S.L. Babiuk, and M.E. Baca-Estrada Novel vaccine strategies Adv Virus Res 58 29-80 2002 29 80
66. A. Mena, X.P. Ioannou, K.A. Van, S. Van Drunen Little-van den Hurk, Y. Popowych, and L.A. Babiuk Th1/Th2 biasing effects of vaccination in cattle as determined by real-time PCR J Immunol Methods 263 1-2 2002 11 21
67. D.M. Estes, N.M. Closser, and G.K. Allen IFN-gamma stimulates IgG2 production from bovine B cells costimulated with anti-mu and mitogen Cell Immunol 154 1 1994 287 295
68. D.M. Estes, W. Tuo, W.C. Brown, and J. Goin Effects of type I/type II interferons and transforming growth factor-beta on B-cell differentiation and proliferation. Definition of costimulation and cytokine requirements for immunoglobulin synthesis and expression Immunology 95 4 1998 604 611